Upload Avatar (500 x 500)
Ronghui Du
rhdu@nju.edu.cn
Chinese, English
Jiangsu
Nanjing University
Medical School
  • 2002.9 – 2005.6 Ph.D. in Pharmacology: China Pharmaceutical University
  • 2009.4 – 2011.12 Postdoctoral in Biology: Nanjing University School of Life Sciences
  • 2015.10 – 2016.10 Postdoctoral in Biochemistry and Molecular Pharmacology: Harvard Medical School
  • 2005/9 - Present - Nanjing University, School of Medicine - Lecturer, Associate Professor
Mechanisms and drug targets of cardiovascular diseases such as atherosclerosis and diabetic vascular injury
Biomarkers and drug target validation for inflammation-related diseases such as atherosclerosis, adenomyosis, and tumors based on multi-omics
Validation and mechanism research of traditional Chinese medicine monomers or compounds in disease treatment
Cardiovascular Diseases Atherosclerosis Diabetic Vascular Injury Drug Targets Multi-Omics Biomarkers Inflammation Adenomyosis Tumors Traditional Chinese Medicine

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.